TOT BIOPHARM International Company Limited (HKG:1875)

HKG:1875 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,468	1,383	1,522	1,855	2,627	2,648
Market Cap Growth	-9.14%	-9.14%	-17.92%	-29.40%	-0.79%	5.58%
Enterprise Value	1,483	1,421	1,411	1,963	2,528	2,268
Last Close Price	1.90	1.79	1.97	2.40	4.27	4.41
PE Ratio	37.25	37.40	-	-	-	-
PS Ratio	1.26	1.18	1.77	3.71	28.04	99.14
PB Ratio	1.89	1.78	2.01	2.29	6.39	3.83
P/TBV Ratio	1.91	1.80	2.04	2.31	6.49	3.85
P/OCF Ratio	11.85	11.17	24.49	27.38	-	-
EV/Sales Ratio	1.27	1.22	1.64	3.93	26.99	84.90
EV/EBITDA Ratio	13.95	13.59	72.14	-	-	-
EV/EBIT Ratio	37.57	36.00	-	-	-	-
Debt / Equity Ratio	0.54	0.54	0.50	0.41	0.62	0.01
Debt / EBITDA Ratio	3.96	3.96	17.06	-	-	-
Asset Turnover	0.75	0.75	0.58	0.45	0.11	0.03
Inventory Turnover	2.49	2.49	1.70	0.94	1.80	0.39
Quick Ratio	1.44	1.44	1.42	2.03	0.99	4.40
Current Ratio	1.79	1.79	1.81	2.46	1.17	4.72
Return on Equity (ROE)	4.91%	4.91%	-5.39%	-9.53%	-56.94%	-40.05%
Return on Assets (ROA)	1.58%	1.58%	-0.98%	-2.47%	-23.63%	-21.96%
Return on Capital (ROIC)	2.15%	2.15%	-1.29%	-3.14%	-28.17%	-23.92%
Return on Capital Employed (ROCE)	3.40%	3.40%	-	-	-	-
Earnings Yield	2.52%	2.67%	-2.73%	-3.04%	-12.21%	-12.94%
FCF Yield	-0.46%	-0.49%	-10.19%	-10.91%	-13.43%	-12.72%
Buyback Yield / Dilution	-	-	-13.44%	-11.50%	-0.53%	-69.92%

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.